EUVIMEDEUVIMED entdecken
Open Access

Elucidating CD4+ and CD8+ T-cell involvement in patients with vancomycin-induced DRESS

Joshua Gardner iD, Silvia Martinez-Rivera, James Line, Paul Thomson, Elsie Clarke, Andrew Gibson, Matthew S Krantz, Michael Ardern-Jones iD, Elizabeth J Phillips iD, Dean J Naisbitt iD

Toxicological Sciences · 01.08.2025 · 206 (2) · 420-432

DOI: 10.1093/toxsci/kfaf074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Sciences, online erschienen am 27.05.2025. Verfasst von Joshua Gardner und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, Centre for Drug Safety Science, The University of Liverpool, Liverpool L69 3GE, United Kingdom. Hauptthemen laut MEDLINE: Vancomycin, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, Drug Hypersensitivity Syndrome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, MRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vancomycin, a glycopeptide antibiotic used to treat severe Gram-positive bacterial infections, is associated with the development of drug reaction with eosinophilia and systemic symptoms (DRESS) in individuals expressing HLA-A*32:01. Previous studies have identified the potential role of T-cells using HLA-A*32:01-positive healthy donor models. However, DRESS pathogenesis remains poorly defined, and a deeper mechanistic understanding is required to aid the diagnosis and prediction of vancomycin-induced DRESS. The present study aims to elucidate CD4+ and CD8+ T-cell involvement within the pathogenesis of vancomycin-induced DRESS following the isolation and functional study of cloned T-cells from hypersensitive patients. CD4+ and CD8+ vancomycin-responsive T-cell clones (TCCs) were generated by serial dilution from peripheral blood mononuclear cells collected from suspected vancomycin-DRESS patients. Functionality of drug-responsive TCCs was assessed using T-cell proliferation ([3H]-thymidine). Cytokine analysis was performed using intracellular cytokine staining, enzyme-linked immunospot assay, and LEGENDplex immunoassays. Vancomycin-responsive TCCs expressing CD4+ and CD8+ phenotypes were successfully generated from suspected vancomycin-DRESS patients (n = 3). CD45RO+ memory T-cells were the primary activated population, with both CD4+ and CD8+ T-cells associated with the release of IFN-γ, IL-5, IL-13, granzyme B, and perforin. Vancomycin-responsive CD4+ and CD8+ T-cells are activated by direct, pharmacological interactions, with antigen presentation possible through HLA class I and HLA class II molecules. This study provides in vitro evidence for the dual role of antigen-specific CD4+ and CD8+ T-cells within the pathogenesis of vancomycin-induced DRESS. This has been demonstrated following the generation of cloned T-cells with strong vancomycin specificity from patients presenting with vancomycin-DRESS and positive for expression of HLA-A*32:01.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesDrug Hypersensitivity SyndromeAnti-Bacterial AgentsHumansMaleFemaleMiddle AgedAdultCytokinesCell ProliferationLymphocyte Activation

Stichwörter der Autor:innen

DRESSHLAT-lymphocytescytokinesdrug hypersensitivityvancomycin

Substanzen

VancomycinAnti-Bacterial AgentsCytokines

Autor:innen und Institutionen

  • Department of Pharmacology and Therapeutics, Centre for Drug Safety Science, The University of Liverpool, Liverpool L69 3GE, United Kingdom.
  • Federal Institute of Biology, University Hospital of Toulouse, Toulouse 31000, France.
  • Institute for Immunology & Infectious Diseases, Murdoch University, Perth 6150, Australia.
  • Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University, Nashville, TN 37232, United States.
  • Clinical Experimental Sciences, University of Southampton Faculty of Medicine, Sir Henry Wellcome Laboratories, Southampton General Hospital, Southampton SO16 6YD, United Kingdom.

ORCID-Profile: Joshua Gardner, Michael Ardern-Jones, Elizabeth J Phillips, Dean J Naisbitt

Förderung

  • NIAID NIH HHS
  • MRC

Zitieren

APA

Gardner, J., Martinez-Rivera, S., Line, J., Thomson, P., Clarke, E., Gibson, A., Krantz, M. S., Ardern-Jones, M., Phillips, E. J., & Naisbitt, D. J. (2025). Elucidating CD4+ and CD8+ T-cell involvement in patients with vancomycin-induced DRESS. Toxicological Sciences, 206(2), 420-432. https://doi.org/10.1093/toxsci/kfaf074

Vancouver

Gardner J, Martinez-Rivera S, Line J, Thomson P, Clarke E, Gibson A, et al. Elucidating CD4+ and CD8+ T-cell involvement in patients with vancomycin-induced DRESS. Toxicological Sciences. 2025;206(2):420-432. doi:10.1093/toxsci/kfaf074

BibTeX
@article{Gardner2025,
  author = {Gardner, Joshua and Martinez-Rivera, Silvia and Line, James and Thomson, Paul and Clarke, Elsie and Gibson, Andrew and Krantz, Matthew S and Ardern-Jones, Michael and Phillips, Elizabeth J and Naisbitt, Dean J},
  title = {Elucidating CD4+ and CD8+ T-cell involvement in patients with vancomycin-induced DRESS},
  journal = {Toxicological Sciences},
  year = {2025},
  volume = {206},
  number = {2},
  pages = {420--432},
  doi = {10.1093/toxsci/kfaf074}
}
Kostenlos starten →